Ryan A. Knudson

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

Ayalew Tefferi, Terra L. Lasho, Christy M. Finke et al. · Leukemia · 2014 · 543 citations

Medicine, Genetics, Hematology +16

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Edgardo R. Parrilla Castellar, Elaine S. Jaffe, Jonathan Said et al. · Blood · 2014 · 466 citations · Full text

Medicine, Oncology, Pathology +16

Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases

Ruben A. Mesa, Chin‐Yang Li, Rhett P. Ketterling et al. · Blood · 2004 · 387 citations · Full text

Medicine, Hematology, Oncology +14

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

Paola Guglielmelli, Terra L. Lasho, Giada Rotunno et al. · Leukemia · 2014 · 308 citations · Full text

Medicine, Genetics, Hematology +13

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

Mrinal M. Patnaik, Raphaël Itzykson, Terra L. Lasho et al. · Leukemia · 2014 · 282 citations

Medicine, Hematology, Oncology +14